Long-Term Results and Competing Risk Analysis of the H89 Trial in Patients With Advanced-Stage Hodgkin Lymphoma: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)
Blood - United States
doi 10.1182/blood-2005-11-4429
Full Text
Open PDFAbstract
Available in full text
Date
June 15, 2006
Authors
Publisher
American Society of Hematology